Back to News
Market Impact: 0.28
Medtronic Wins FDA Clearance For LigaSure RAS Maryland Instrument On Hugo RAS System
Source: Nasdaq
Healthcare & BiotechProduct LaunchesRegulation & LegislationTechnology & Innovation
Medtronic announced FDA clearance for its LigaSure RAS Maryland jaw device for use with the Hugo robotic-assisted surgery system in the U.S. The clearance expands the instrument suite available to surgeons using Hugo, supporting Medtronic's robotic-surgery product offering, although no financial impact or sales outlook was disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.42
Ticker Sentiment
MDT0.68
More News
- Medtronic Just Retired 55 Million Shares Without Spending Cash. Is the Stock a Buy?
- If a Bear Market Is Coming, History Says These Stocks Could Be the Smartest to Own
- Companies promised AI gains— here's how the payoff showed up in earnings
- SpaceX loses bid to toss NAACP lawsuit over Memphis data center air pollution
- U.S workers just took home their smallest share of capital since at least 1947—and the lowest ever recorded
- Fears over $828 billion AI capex spending spree help erase $1 trillion in market value